NCT01727791View on ClinicalTrials.gov

A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy Lactating Women
Interventions
DRUG

pregabalin (Lyrica)

Subjects will receive a single 150 mg dose of pregabalin in the evening of Day 1, a 150 mg dose of pregabalin in the morning and evening of Day 2 and a 150 mg dose in the morning of Day 3.

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01727791 - A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women | Biotech Hunter | Biotech Hunter